PubMed

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.

Shaughnessy PJ, Bolwell BJ, van Besien K, Mistrik M, Grigg A, Dodds A, Prince HM, Durrant S, Ilhan O, Parenti D, Gallo J, Foss F, Apperley J, Zhang MJ, Horowitz MM, Abhyankar S.

Bone Marrow Transplant. 2009 Nov 16. [Epub ahead of print]PMID: 19915634 [PubMed - as supplied by publisher]Related articles

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.

Quach H, Ritchie D, Stewart AK, Neeson P, Harrison S, Smyth MJ, Prince HM.

Leukemia. 2009 Nov 12. [Epub ahead of print]PMID: 19907437 [PubMed - as supplied by publisher]Related articles

IgA nephropathy associated with cutaneous T cell lymphoma.

Bajel A, Yin Lin M, Hill PA, Goodman D, McCormack C, Foley P, Davison J, Hönemann D, Kenealy M, Lade S, Ryan G, Prince HM.

Leuk Lymphoma. 2009 Oct 28. [Epub ahead of print] No abstract available. PMID: 19863174 [PubMed - as supplied by publisher]Related articles

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.

Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE.

J Clin Oncol. 2009 Nov 10;27(32):5410-7. Epub 2009 Oct 13.PMID: 19826128 [PubMed - in process]Related articles

How we treat mycosis fungoides and Sezary syndrome.

Prince HM, Whittaker S, Hoppe RT.

Blood. 2009 Aug 20. [Epub ahead of print]PMID: 19696197 [PubMed - as supplied by publisher]Related articles

Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.

Gill S, Herbert KE, Prince HM, Wolf MM, Wirth A, Ryan G, Carney DA, Ritchie DS, Davies JM, Seymour JF.

Br J Haematol. 2009 Oct;147(1):83-8. Epub 2009 Aug 19.PMID: 19694718 [PubMed - in process]Related articles

Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma.

Dickinson M, Ritchie D, DeAngelo DJ, Spencer A, Ottmann OG, Fischer T, Bhalla KN, Liu A, Parker K, Scott JW, Bishton M, Prince HM.

Br J Haematol. 2009 Oct;147(1):97-101. Epub 2009 Aug 5.PMID: 19663825 [PubMed - in process]Related articles

Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab.

Kieu V, O'Brien T, Yap LM, Baker C, Foley P, Mason G, Prince HM, McCormack C.

Australas J Dermatol. 2009 Aug;50(3):202-6.PMID: 19659984 [PubMed - indexed for MEDLINE]Related articles

Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?

Peinert S, Carney D, Prince HM, Januszewicz EH, Seymour JF.

Br J Haematol. 2009 Sep;146(6):685-6. Epub 2009 Jul 23. No abstract available. PMID: 19638019 [PubMed - in process]Related articles

The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.

Gill S, Carney D, Ritchie D, Wolf M, Westerman D, Prince HM, Januszewicz H, Seymour JF.

Ann Oncol. 2009 Jul 22. [Epub ahead of print]PMID: 19625344 [PubMed - as supplied by publisher]Related articles

Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report.

Ritchie D, Piekarz RL, Blombery P, Karai LJ, Pittaluga S, Jaffe ES, Raffeld M, Janik JE, Prince HM, Bates SE.

Haematologica. 2009 Nov;94(11):1618-22. Epub 2009 Jul 16.PMID: 19608677 [PubMed - in process]Related articlesFree article

Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors.

Prince HM, Bishton MJ, Johnstone RW.

Future Oncol. 2009 Jun;5(5):601-12. Review.PMID: 19519200 [PubMed - indexed for MEDLINE]Related articles

Clinical studies of histone deacetylase inhibitors.

Prince HM, Bishton MJ, Harrison SJ.

Clin Cancer Res. 2009 Jun 15;15(12):3958-69. Epub 2009 Jun 9. Review.PMID: 19509172 [PubMed - indexed for MEDLINE]Related articles

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

Prince HM, Hönemann D, Spencer A, Rizzieri DA, Stadtmauer EA, Roberts AW, Bahlis N, Tricot G, Bell B, Demarini DJ, Benjamin Suttle A, Baker KL, Pandite LN.

Blood. 2009 May 7;113(19):4819-20. No abstract available. PMID: 19423744 [PubMed - indexed for MEDLINE]Related articles

Successful treatment of lymphomatoid papulosis with photodynamic therapy.

Rodrigues M, McCormack C, Yap LM, Prince HM, Roberts H, Williams R, Foley P.

Australas J Dermatol. 2009 May;50(2):129-32.PMID: 19397568 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy results from an international expanded access programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patients.

Quach H, Horvath N, Cannell P, Mikhael JR, Butcher BE, Prince HM.

Intern Med J. 2009 May;39(5):290-5. Epub 2008 Jun 28.PMID: 19371392 [PubMed - in process]Related articles

Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.

Spencer A, Prince HM, Roberts AW, Prosser IW, Bradstock KF, Coyle L, Gill DS, Horvath N, Reynolds J, Kennedy N.

J Clin Oncol. 2009 Apr 10;27(11):1788-93. Epub 2009 Mar 9.PMID: 19273705 [PubMed - indexed for MEDLINE]Related articles

Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.

Dickinson M, Prince HM, Kirsa S, Zannettino A, Gibbs SD, Mileshkin L, O'Grady J, Seymour JF, Szer J, Horvath N, Joshua DE.

Intern Med J. 2009 May;39(5):304-16. Epub 2008 Nov 3.PMID: 19220531 [PubMed - in process]Related articles

Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma.

Peinert S, Kamel S, Seymour JF, Prince HM.

Leuk Lymphoma. 2009 Feb;50(2):303-5. No abstract available. PMID: 19197721 [PubMed - indexed for MEDLINE]Related articles

Predicting durable remissions following thalidomide therapy for relapsed myeloma.

Quach H, Mileshkin L, Seymour JF, Milner A, Ritchie D, Harrison S, Westerman D, Prince HM.

Leuk Lymphoma. 2009 Feb;50(2):223-9.PMID: 19194832 [PubMed - indexed for MEDLINE]Related articles

Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma.

Dawson MA, Opat SS, Taouk Y, Donovan M, Zammit M, Monaghan K, Horvath N, Roberts AW, Prince HM, Hertzberg M, McLean CA, Spencer A.

Clin Cancer Res. 2009 Jan 15;15(2):714-22.PMID: 19147779 [PubMed - indexed for MEDLINE]Related articles

Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma.

Kim PJ, Hicks RJ, Wirth A, Ryan G, Seymour JF, Prince HM, Mac Manus MP.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):740-6. Epub 2008 Nov 27.PMID: 19038505 [PubMed - indexed for MEDLINE]Related articles

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program.

Mikhael JR, Belch AR, Prince HM, Lucio MN, Maiolino A, Corso A, Petrucci MT, Musto P, Komarnicki M, Stewart AK.

Br J Haematol. 2009 Jan;144(2):169-75. Epub 2008 Nov 19.PMID: 19036114 [PubMed - indexed for MEDLINE]Related articles

Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator.

Herbert KE, Morgan S, Prince HM, Westerman DA, Wolf MM, Carney DA, Yuen K, di Iulio J, Seymour JF.

Leukemia. 2009 Feb;23(2):305-12. Epub 2008 Nov 6.PMID: 18987661 [PubMed - indexed for MEDLINE]Related articles

Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol.

Arulogun S, Prince HM, Gambell P, Lade S, Ryan G, Eaton E, McCormack C.

J Am Acad Dermatol. 2008 Oct;59(4):589-95. Epub 2008 Jul 24.PMID: 18656282 [PubMed - indexed for MEDLINE]Related articles

[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma.

Gill S, Wolf M, Prince HM, Januszewicz H, Ritchie D, Hicks RJ, Seymour JF.

Clin Lymphoma Myeloma. 2008 Jun;8(3):159-65.PMID: 18650179 [PubMed - indexed for MEDLINE]Related articles

Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation.

Arulogun SO, Prince HM, Ng J, Lade S, Ryan GF, Blewitt O, McCormack C.

Blood. 2008 Oct 15;112(8):3082-7. Epub 2008 Jul 22.PMID: 18647960 [PubMed - indexed for MEDLINE]Related articlesFree article

Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma.

Ellis L, Pan Y, Smyth GK, George DJ, McCormack C, Williams-Truax R, Mita M, Beck J, Burris H, Ryan G, Atadja P, Butterfoss D, Dugan M, Culver K, Johnstone RW, Prince HM.

Clin Cancer Res. 2008 Jul 15;14(14):4500-10.PMID: 18628465 [PubMed - indexed for MEDLINE]Related articlesFree article

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.

Flowers ME, Apperley JF, van Besien K, Elmaagacli A, Grigg A, Reddy V, Bacigalupo A, Kolb HJ, Bouzas L, Michallet M, Prince HM, Knobler R, Parenti D, Gallo J, Greinix HT.

Blood. 2008 Oct 1;112(7):2667-74. Epub 2008 Jul 11. Erratum in: Blood. 2009 Apr 30;113(18):4478. PMID: 18621929 [PubMed - indexed for MEDLINE]Related articlesFree article

The use of experimental murine models to assess novel agents of hematopoietic stem and progenitor cell mobilization.

Herbert KE, Lévesque JP, Haylock DN, Prince HM.

Biol Blood Marrow Transplant. 2008 Jun;14(6):603-21. Review. Erratum in: Biol Blood Marrow Transplant. 2008 Aug;14(8):947. Prince, M [corrected to Prince, H Miles]. PMID: 18489986 [PubMed - indexed for MEDLINE]Related articles

In vivo tracking of dendritic cells in patients with multiple myeloma.

Prince HM, Wall DM, Ritchie D, Honemann D, Harrrison S, Quach H, Thompson M, Hicks R, Lau E, Davison J, Loudovaris M, Moloney J, Loveland B, Bartholeyns J, Katsifis A, Mileshkin L.

J Immunother. 2008 Feb-Mar;31(2):166-79.PMID: 18481386 [PubMed - indexed for MEDLINE]Related articles

Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set.

Bishton MJ, Hicks RJ, Prince HM, Ritchie DS, Wolf M, Seymour JF.

Leukemia. 2008 Dec;22(12):2259-60; author reply 2260-1. Epub 2008 May 15. No abstract available. PMID: 18480835 [PubMed - indexed for MEDLINE]Related articles

Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients.

Gill S, Lane SW, Crawford J, Cull G, Joske D, Marlton P, Mollee PN, Prince HM, Seymour JF.

Ann Hematol. 2008 Sep;87(9):727-34. Epub 2008 Apr 10.PMID: 18401583 [PubMed - indexed for MEDLINE]Related articles

The development of novel immunotherapeutic approaches in multiple myeloma.

Peinert S, Prince HM, Harrison S.

Leuk Lymphoma. 2008 Apr;49(4):652-4. Review. No abstract available. PMID: 18398729 [PubMed - indexed for MEDLINE]Related articles

Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice.

Westwood JA, Murray WK, Trivett M, Shin A, Neeson P, MacGregor DP, Haynes NM, Trapani JA, Mayura-Guru P, Fox S, Peinert S, Honemann D, Prince HM, Ritchie D, Scott AM, Smyth FE, Smyth MJ, Darcy PK, Kershaw MH.

Gene Ther. 2008 Jul;15(14):1056-66. Epub 2008 Mar 27.PMID: 18369322 [PubMed - indexed for MEDLINE]Related articles

Histone deacetylase inhibitors in lymphoma and solid malignancies.

Rasheed W, Bishton M, Johnstone RW, Prince HM.

Expert Rev Anticancer Ther. 2008 Mar;8(3):413-32. Review.PMID: 18366289 [PubMed - indexed for MEDLINE]Related articles

The potential of histone deacetylase inhibitors for the treatment of multiple myeloma.

Prince HM, Bishton M, Harrison S.

Leuk Lymphoma. 2008 Mar;49(3):385-7.PMID: 18297514 [PubMed - indexed for MEDLINE]Related articles

Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade.

Sutherland JS, Spyroglou L, Muirhead JL, Heng TS, Prieto-Hinojosa A, Prince HM, Chidgey AP, Schwarer AP, Boyd RL.

Clin Cancer Res. 2008 Feb 15;14(4):1138-49.PMID: 18281548 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinically relevant QTc prolongation is not associated with current dose schedules of LBH589 (panobinostat).

Zhang L, Lebwohl D, Masson E, Laird G, Cooper MR, Prince HM.

J Clin Oncol. 2008 Jan 10;26(2):332-3; discussion 333-4. No abstract available. Erratum in: J Clin Oncol.2008 Apr 20;26(12):2066. PMID: 18182676 [PubMed - indexed for MEDLINE]Related articles

Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.

Bercovici N, Haicheur N, Massicard S, Vernel-Pauillac F, Adotevi O, Landais D, Gorin I, Robert C, Prince HM, Grob JJ, Leccia MT, Lesimple T, Wijdenes J, Bartholeyns J, Fridman WH, Salcedo M, Ferries E, Tartour E.

J Immunother. 2008 Jan;31(1):101-12.PMID: 18157017 [PubMed - indexed for MEDLINE]Related articles

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau JL, Dmoszynska A, San Miguel J, Hellmann A, Facon T, Foà R, Corso A, Masliak Z, Olesnyckyj M, Yu Z, Patin J, Zeldis JB, Knight RD; Multiple Myeloma (010) Study Investigators.

N Engl J Med. 2007 Nov 22;357(21):2123-32. Erratum in: N Engl J Med. 2009 Jul 30;361(5):544. PMID: 18032762 [PubMed - indexed for MEDLINE]Related articlesFree article

Successful treatment of Behçet's disease with lenalidomide.

Green J, Upjohn E, McCormack C, Zeldis J, Prince HM.

Br J Dermatol. 2008 Jan;158(1):197-8. Epub 2007 Nov 6. No abstract available. PMID: 17986298 [PubMed - indexed for MEDLINE]Related articles

Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.

Bishton M, Kenealy M, Johnstone R, Rasheed W, Prince HM.

Expert Rev Anticancer Ther. 2007 Oct;7(10):1439-49. Review.PMID: 17944568 [PubMed - indexed for MEDLINE]Related articles

Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanoma.

Gill S, Shapiro J, Westerman D, Prince HM.

J Clin Oncol. 2007 Oct 1;25(28):4493-4. No abstract available. PMID: 17906211 [PubMed - indexed for MEDLINE]Related articles

Treatment strategies in elderly patients with multiple myeloma: current status.

Quach H, Prince HM, Mileshkin L.

Drugs Aging. 2007;24(10):829-50. Review.PMID: 17896832 [PubMed - indexed for MEDLINE]Related articles

Spinal epidural lipomatosis in myeloma.

Liew MS, Bishton MJ, Januszewicz H, Alatakis S, Prince HM.

Leuk Lymphoma. 2007 Oct;48(10):2068-70. No abstract available. PMID: 17852706 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy of combining ATRA with G-CSF in HSPC mobilization; a pilot study in multiple myeloma and non-Hodgkin's lymphoma patients.

Herbert KE, True S, McArthur G, Prince HM.

Bone Marrow Transplant. 2007 Oct;40(8):801-3. Epub 2007 Aug 6. No abstract available. PMID: 17680017 [PubMed - indexed for MEDLINE]Related articles

Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.

Mileshkin L, Honemann D, Gambell P, Trivett M, Hayakawa Y, Smyth M, Beshay V, Ritchie D, Simmons P, Milner AD, Zeldis JB, Prince HM.

Haematologica. 2007 Aug;92(8):1075-82. Epub 2007 Jul 20.PMID: 17640854 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison.

Prince HM, Adena M, Smith DK, Hertel J.

Eur J Haematol. 2007 Aug;79(2):93-9. Epub 2007 Jun 28.PMID: 17608711 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study.

Feyler S, Prince HM, Pearce R, Towlson K, Nivison-Smith I, Schey S, Gibson J, Patton N, Bradstock K, Marks DI, Cook G.

Bone Marrow Transplant. 2007 Sep;40(5):443-50. Epub 2007 Jun 25.PMID: 17589529 [PubMed - indexed for MEDLINE]Related articles